US 12,109,210 B2
Methods for treating mast cell tumors
Chuan-Ching Yang, Taipei (TW); Mao-Yuan Lin, Taipei (TW); Shu-Ying Cheng, Taipei (TW); and Yi-Jhen Feng, Taipei (TW)
Assigned to GONGWIN BIOPHARM CO., LTD, Taipei (TW)
Filed by GONGWIN BIOPHARM CO., LTD, Taipei (TW)
Filed on Sep. 29, 2021, as Appl. No. 17/489,353.
Prior Publication US 2023/0098310 A1, Mar. 30, 2023
Int. Cl. A61K 31/498 (2006.01); A61P 35/00 (2006.01)
CPC A61K 31/498 (2013.01) [A61P 35/00 (2018.01)] 13 Claims
OG exemplary drawing
 
1. A method for treating a mast cell tumor in a subject in need thereof, comprising administering a therapeutically effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a benzenesulfonamide derivative and a pharmaceutically acceptable carrier thereof, wherein the benzenesulfonamide derivative is para-toluene sulfonamide, ortho-toluene sulfonamide, or meta-toluene sulfonamide, or a pharmaceutically acceptable salt thereof,
wherein the pharmaceutically acceptable carrier is at least one selected from the group consisting of alkylene glycol, sebacic acid, dimethyl sulfoxide, and any combination thereof, and
wherein the pharmaceutical composition is administered to the subject by an intratumoral injection.